Optiver Holding
OPTN

Optiver Holding’s OptiNose OPTN Stock Holding History

Optiver Holding’s Portfolio OPTN Stock Details OPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-586
Closed -$26K – 776
2021
Q4 		$26K Hold
586
– – ﹤0.01% 527
2021
Q3 		$26K Hold
586
– – ﹤0.01% 423
2021
Q2 		$27K Buy
+586
New +$29.9K ﹤0.01% 335

Other funds holding OPTN

MPU
MVM Partners (UK) London, United Kingdom $149M AUM 6.81% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Optiver Holding's OPTN Position: Q1 2022 in Review

Optiver Holding sold out of OptiNose (OPTN) in Q1 2022, closing a stake of 586 shares — an estimated $26K sold.

Optiver Holding first reported a position in OPTN in Q2 2021 and held it in 3 quarters. The position peaked at $27K in Q2 2021. 44 funds tracked by Wall St. Rank hold OPTN as of Q1 2022.

  • Optiver Holding reported no remaining OptiNose position as of Q1 2022 after selling out during the quarter.
  • Optiver Holding sold 586 OptiNose shares in Q1 2022, an estimated $26K.
  • Optiver Holding first reported a position in OptiNose in Q2 2021 and held it in 3 quarters.
  • Optiver Holding's OptiNose position peaked at $27K in Q2 2021.
  • 44 funds tracked by Wall St. Rank held OptiNose as of Q1 2022.

Based on Optiver Holding's 13F filing for Q1 2022, filed 16 May 2022.